According to the release, Southwoods can offer this therapy with the new HYDRO Robotic System, a treatment for men with ...
THOMASVILLE — Archbold is now offering Aquablation therapy with the new HYDROS™ Robotic System, the next-generation platform to treat men suffering from benign prostatic hyperplasia (BPH). BPH, ...
The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...
Amazon S3 on MSN
Key symptoms of an enlarged prostate: A must-read for men
Benign prostate hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland, which is generally the shape and size ...
DUBLIN, Aug. 25, 2025 /PRNewswire/ -- ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
Benign prostatic hyperplasia (BPH) is a non-cancerous prostate tissue growth affecting men 40 and older. BPH can cause difficulty urinating and may be exacerbated by some cold and allergy medications.
IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NYMXF) [OTC Markets – NYMXF] (the “Company”) is pleased to announce today that a new formal submission has been ...
BOSTON and YOKNEAM, Israel, April 22, 2025 /PRNewswire/ -- Butterfly Medical, a medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), announced ...
TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...
MONTREAL, QUEBEC, CANADA, February 9, 2023 /EINPresswire.com/ -- BPH Canada announces the February 2023 opening of a private BPH treatment clinic serving Canada, in ...
HASBROUCK HEIGHTS, N.J., April 10, 2018 (GLOBE NEWSWIRE) -- A new online published commentary about Nymox’s (NASDAQ:NYMX) Fexapotide 2018 clinical trial results publication in World Journal of Urology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback